(Date:12/4/2009)... water and fruit consumption leads to success, st...y News) -- Increased exercise, reduced soda consum...ve weight control strategies for adolescents, a ne...scents about their weight-control strategies and l... weight and 68 had not. The responses were grouped...
(Date:12/4/2009)...ec. 4 Substantial progress has bee...mmunity,s ability to diagnose and treat epilepsy a...sy management has not reached most of the 50 milli...nearly three million people in the United States w... Schachter, M.D., president of the American Epilep...
(Date:12/4/2009)...lance urged for at-risk patient groups , ...od cancers, particularly Ewing sarcomas and centra...currence, U.S. researchers have found. , The st...rvivors of the most common pediatric cancers who w...y. , The researchers found that the overall can...
(Date:12/4/2009)...erol-lowering drugs known as statins are among the...tudy by researchers at Fred Hutchinson Cancer Rese...m cell transplant patients from one of the most se...apy: graft-versus-host disease, or GVHD. The findi...e journal Blood . , In a retrospective study of ...
(Date:12/4/2009)... of risks, many hesitate to take breast cancer dru...hDay News) -- Worries about side effects are a maj...high risk for breast cancer are willing to take th...dy finds. , In an effort to inform women about ...t the University of Michigan Comprehensive Cancer ...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2...wait Ministry of Health stockpiles thyroid-blockin...es , , MOORESVILLE, N.C., Jan. 22 Nukepills.com ...lion doses) of ThyroShield(TM) Potassium Iodide to...otecting its citizens during a nuclear radiation e...
...MILTON, Bermuda, Jan. 22 Warner Chilcott Limited ...ue its 2009 Financial Guidance after market close ...ng a press release, Roger Boissonneault, President... discuss the 2009 Financial Guidance for all inter...
... , , , , CARLSBAD, Cal...automated molecular testing solutions announced to... to demonstrate the value of genetic variants in d...artery disease, peripheral vascular disease and ce...
... Health Industry Professiona...ama , New York (PRWEB) Ja...published a brief entitled 10 Minutes on Health R...are coverage for the nation,s employers and the ...
... To encourage dental care i...edures, including the anesthesia, from January thr...od dental health, you may avoid some serious and e...g the health and well-being of your pets. The numb...
... recent survey by Medical College of Wisconsin res...ert Hospital Emergency Department revealed that Me...ell prepared for disasters as the rest of the coun...22, 2009. , The purpose of the survey was to ass...
Other Medicine News:Health News:Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com 2Health News:AutoGenomics CYP 2C19 Test Used in Study to Personalize Clopidogrel (Plavix) Dosing in Patients 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 2Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 3Health News:Media Alert: PricewaterhouseCoopers Publishes Brief on the Impact of Government Health Reform on U.S. Employers 4Health News:Indian Head Animal Hospital Announces Dental Discounts for Pets through March 31st 2Health News:Personal disaster preparedness 2... Magen BioSciences,Inc., a specialty dermatology ...r in the March 9, 2007 issue of the journal,Cell b..., M.D.,Ph.D., that identifies two new functions f...of skin. Fisher,s study shows that in,addition to ...s in,the body, p53 also plays a key role in prompt...
...ced the number of,new or enlarged lesions compared... at upcoming medical meeting -, CAMBRIDGE, Mass. a...stCall/ -- Biogen Idec, Inc. and PDL BioPharma, In...rial, a Phase 2,randomized, double-blind, placebo...ndpoint in relapsing multiple sclerosis (MS),patie...
Other Medicine Technology:Study in Cell by Magen BioSciences Co-Founder David E. Fisher,Identifies New Roles in Skin Cancer Prevention for Key Tumor,Suppressor Protein 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5Vascular ClearWay Irrigating PTFE Balloon Catheter
PureVision Contact Lenses
Arx Ceramic Spinal Spacer System
QC 900 Hematocrit Control
Medicine Products: